ARG10813
anti-Natriuretic Peptide Receptor A antibody
anti-Natriuretic Peptide Receptor A antibody for Confocal microscopy (Confocal),Dot blot,ELISA,ICC/IF,IHC-Whole mount,Immunohistochemistry,Immunoprecipitation,Western blot and Human,Mouse,Rat
Overview
Product Description | Rabbit Polyclonal antibody recognizes Natriuretic Peptide Receptor A |
---|---|
Tested Reactivity | Hu, Ms, Rat |
Tested Application | Confocal, Dot, ELISA, ICC/IF, IHC, IHC-Wmt, IP, WB |
Host | Rabbit |
Clonality | Polyclonal |
Isotype | IgG |
Target Name | Natriuretic Peptide Receptor A |
Antigen Species | Human |
Immunogen | Synthetic peptide around aa. 1042-1057 of Human Natriuretic Peptide Receptor A. (VRTYWLLGERGCSTRG) |
Conjugation | Un-conjugated |
Alternate Names | ANPa; GUCY2A; GC-A; ANPRA; Atrial natriuretic peptide receptor 1; Guanylate cyclase A; NPR-A; NPRA; GUC2A; Atrial natriuretic peptide receptor type A; EC 4.6.1.2; ANP-A; ANPR-A |
Application Instructions
Application Suggestion |
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Application Note | * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. |
Properties
Form | Liquid |
---|---|
Purification | Affinity purified. |
Buffer | Tris-Glycine Buffer (pH 7.4 - 7.8), Hepes, 0.02% Sodium azide, 30% Glycerol and 0.5% BSA. |
Preservative | 0.02% Sodium azide |
Stabilizer | 30% Glycerol and 0.5% BSA |
Concentration | 0.75 mg/ml |
Storage Instruction | For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. |
Note | For laboratory research only, not for drug, diagnostic or other use. |
Bioinformation
Database Links | |
---|---|
Gene Symbol | NPR1 |
Gene Full Name | natriuretic peptide receptor 1 |
Background | Guanylyl cyclases, catalyzing the production of cGMP from GTP, are classified as soluble and membrane forms (Garbers and Lowe, 1994 [PubMed 7982997]). The membrane guanylyl cyclases, often termed guanylyl cyclases A through F, form a family of cell-surface receptors with a similar topographic structure: an extracellular ligand-binding domain, a single membrane-spanning domain, and an intracellular region that contains a protein kinase-like domain and a cyclase catalytic domain. GC-A and GC-B function as receptors for natriuretic peptides; they are also referred to as atrial natriuretic peptide receptor A (NPR1) and type B (NPR2; MIM 108961). Also see NPR3 (MIM 108962), which encodes a protein with only the ligand-binding transmembrane and 37-amino acid cytoplasmic domains. NPR1 is a membrane-bound guanylate cyclase that serves as the receptor for both atrial and brain natriuretic peptides (ANP (MIM 108780) and BNP (MIM 600295), respectively).[supplied by OMIM, May 2009] |
Function | Receptor for the atrial natriuretic peptide NPPA/ANP and the brain natriuretic peptide NPPB/BNP which are potent vasoactive hormones playing a key role in cardiovascular homeostasis. Has guanylate cyclase activity upon binding of the ligand. [UniProt] |
Calculated MW | 119 kDa |
PTM | Phosphorylation of the protein kinase-like domain is required for full activation by ANP. |